JP2001521902A5 - - Google Patents

Download PDF

Info

Publication number
JP2001521902A5
JP2001521902A5 JP2000518676A JP2000518676A JP2001521902A5 JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5 JP 2000518676 A JP2000518676 A JP 2000518676A JP 2000518676 A JP2000518676 A JP 2000518676A JP 2001521902 A5 JP2001521902 A5 JP 2001521902A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
crosslinking agent
polymer
monomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000518676A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001521902A (ja
JP4452402B2 (ja
Filing date
Publication date
Priority claimed from US08/964,956 external-priority patent/US5985938A/en
Application filed filed Critical
Publication of JP2001521902A publication Critical patent/JP2001521902A/ja
Publication of JP2001521902A5 publication Critical patent/JP2001521902A5/ja
Application granted granted Critical
Publication of JP4452402B2 publication Critical patent/JP4452402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000518676A 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用 Expired - Lifetime JP4452402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/964,956 1997-11-05
US08/964,956 US5985938A (en) 1997-11-05 1997-11-05 Method for reducing oxalate
PCT/US1998/022606 WO1999022744A1 (en) 1997-11-05 1998-10-26 Use of aliphatic polyamines for reducing oxalate

Publications (3)

Publication Number Publication Date
JP2001521902A JP2001521902A (ja) 2001-11-13
JP2001521902A5 true JP2001521902A5 (cg-RX-API-DMAC7.html) 2006-01-05
JP4452402B2 JP4452402B2 (ja) 2010-04-21

Family

ID=25509224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518676A Expired - Lifetime JP4452402B2 (ja) 1997-11-05 1998-10-26 蓚酸塩を低減させるための脂肪族ポリアミン類の使用

Country Status (10)

Country Link
US (3) US5985938A (cg-RX-API-DMAC7.html)
EP (2) EP1645278A3 (cg-RX-API-DMAC7.html)
JP (1) JP4452402B2 (cg-RX-API-DMAC7.html)
AR (1) AR016001A1 (cg-RX-API-DMAC7.html)
AU (1) AU1364799A (cg-RX-API-DMAC7.html)
CA (1) CA2349620C (cg-RX-API-DMAC7.html)
DE (1) DE69833134T2 (cg-RX-API-DMAC7.html)
TW (1) TW585772B (cg-RX-API-DMAC7.html)
WO (1) WO1999022744A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA989671B (cg-RX-API-DMAC7.html)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US8486389B2 (en) 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US6566407B2 (en) 1997-11-05 2003-05-20 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
GB9927088D0 (en) * 1999-11-17 2000-01-12 Secr Defence Use of poly(diallylamine) polymers
DE10028167B4 (de) * 2000-06-09 2004-02-19 Storch, Rüdiger, Dr. Verwendung von Calciumsalzen zur Entgegenwirkung der Bildung von Oxalatharnsteinen
CN1290515C (zh) * 2001-04-18 2006-12-20 基酶有限公司 低盐含量的聚烯丙胺
WO2002085380A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for treating gout and reducing serum uric acid
EP1923064B1 (en) 2001-04-18 2017-06-28 Genzyme Corporation Use of amine polymer for lowering serum glucose
WO2002085379A1 (en) * 2001-04-18 2002-10-31 Geltex Pharmaceuticals, Inc. Method for improving vascular access in patients with vascular shunts
DK1392331T3 (da) * 2001-04-18 2008-06-23 Genzyme Corp Anvendelse af colesevelam eller sevelamer, hydrogenchlorid til sænkning af serumglucoseniveauet
AU2002257147B9 (en) 2001-04-18 2005-08-18 Genzyme Corporation Methods of treating syndrome X with aliphatic polyamines
EP1416942B1 (en) * 2001-04-18 2007-12-12 Genzyme Corporation Amine polymers for treating gout and binding uric acid
SI1389102T1 (sl) * 2001-04-23 2011-07-29 Shire Int Licensing Bv Uporaba lantanovega karbonata za preprečevanje bolezni ledvičnih kamnov
US7041280B2 (en) * 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
DE60226767D1 (de) * 2001-10-05 2008-07-03 Oxthera Inc Materialien und methoden zum reduzieren der konzentration von oxalat in fluiden
IL161185A0 (en) * 2001-10-09 2004-08-31 Genzyme Corp A method of purifying and drying a polymer hydrogel
US6600011B2 (en) * 2001-10-09 2003-07-29 Genzyme Corporation Process for purification and drying of polymer hydrogels
AU2003282867A1 (en) * 2002-10-22 2004-05-13 Genzyme Corporation Amine polymers for promoting bone formation
US7459502B2 (en) 2003-11-03 2008-12-02 Ilypsa, Inc. Pharmaceutical compositions comprising crosslinked polyamine polymers
US7385012B2 (en) 2003-11-03 2008-06-10 Ilypsa, Inc. Polyamine polymers
US7608674B2 (en) * 2003-11-03 2009-10-27 Ilypsa, Inc. Pharmaceutical compositions comprising cross-linked small molecule amine polymers
US7449605B2 (en) * 2003-11-03 2008-11-11 Ilypsa, Inc. Crosslinked amine polymers
US7767768B2 (en) * 2003-11-03 2010-08-03 Ilypsa, Inc. Crosslinked amine polymers
US7335795B2 (en) * 2004-03-22 2008-02-26 Ilypsa, Inc. Crosslinked amine polymers
DE602005019992D1 (de) 2004-03-30 2010-04-29 Relypsa Inc Kaliumbindende polymere und ihre verwendungen
WO2005110469A2 (en) * 2004-05-07 2005-11-24 Oxthera, Inc. Methods and compositions for reducing oxalate concentrations
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
WO2006072054A1 (en) * 2004-12-30 2006-07-06 Genzyme Corporation Zinc-containing treatments for hyperphosphatemia
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
DK1924246T3 (en) 2005-09-15 2016-01-18 Genzyme Corp PORTION LETTER DEFINITION OF amine polymers
EP1945196A2 (en) * 2005-11-08 2008-07-23 Genzyme Corporation Magnesium-containing polymers for hyperphosphatemia
JP5047190B2 (ja) * 2005-12-14 2012-10-10 オクセラ インコーポレイテッド シュウ酸塩関連疾患を治療または予防するための医薬組成物および方法
ES2362897T3 (es) * 2005-12-16 2011-07-14 Oxthera, Inc. Composiciones y métodos para reducción del oxalato.
EP2016114A2 (en) * 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
US20100135950A1 (en) * 2006-07-05 2010-06-03 Genzyme Corporation Iron(II)-Containing Treatments for Hyperphosphatemia
SG188908A1 (en) 2006-07-14 2013-04-30 Wisconsin Alumni Res Found Adsorptive membranes for trapping viruses
WO2008011047A2 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
WO2008105911A2 (en) 2006-08-02 2008-09-04 Altus Pharmaceuticals Inc. Crystallized oxalate decarboxylase and methods of use
EP2066293A2 (en) 2006-09-29 2009-06-10 Genzyme Corporation Amide dendrimer compositions
CN101568349B (zh) * 2006-10-25 2012-09-19 威斯康星大学校友研究基金会 减少磷酸盐吸收的方法
EP2076543B1 (en) * 2006-10-26 2016-01-27 Wisconsin Alumni Research Foundation Methods of reducing phosphate absorption
JP2010513271A (ja) 2006-12-14 2010-04-30 ゲンズイメ コーポレーション アミド−アミンポリマー組成物
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
WO2008113364A2 (en) * 2007-03-20 2008-09-25 Recepticon Aps Amino derivatives to prevent nephrotoxicity and cancer
WO2008133954A1 (en) * 2007-04-27 2008-11-06 Genzyme Corporation Amido-amine dendrimer compositions
WO2009078958A1 (en) * 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
FR2928373B1 (fr) 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
WO2009154747A1 (en) * 2008-06-20 2009-12-23 Genzyme Corporation Pharmaceutical compositions
WO2010123039A1 (ja) * 2009-04-21 2010-10-28 株式会社医学生物学研究所 生物学的材料の不動化を行うための組成物
WO2014113648A1 (en) 2013-01-18 2014-07-24 Allena Pharmaceuticals, Inc. Crystallized oxalate decarboxylase and methods of use
SG11201506413PA (en) * 2013-03-15 2015-09-29 Genzyme Corp Sequestrants of advanced glycation end product (age) precursors
ES2875060T3 (es) 2013-06-07 2021-11-08 Allena Pharmaceuticals Inc Composiciones y dispositivos para diálisis
US10435528B2 (en) 2013-09-17 2019-10-08 Aquanano Llc High-capacity anion exchange materials
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2
WO2016161455A2 (en) 2015-04-02 2016-10-06 Captozyme, Llc High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
GB201718803D0 (en) * 2017-11-14 2017-12-27 Phoenix Molecular Pte Ltd Method for isolation of nucleic acids
US11993670B2 (en) 2018-06-06 2024-05-28 The Board Of Trustees Of The University Of Illinois Zwitterionic biocompatible polymers, methods, and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4198396A (en) * 1974-07-03 1980-04-15 Warren-Teed Laboratories, Inc. Dissolution of gallstones
US4143130A (en) * 1977-08-29 1979-03-06 Warren-Teed Laboratories, Inc. Method for treating kidney stones
JPS60202869A (ja) * 1984-03-26 1985-10-14 Ajinomoto Co Inc 大環状ポリアミン誘導体及びその用途
DE3727082A1 (de) * 1987-08-14 1989-02-23 Goedecke Ag Pharmazeutische zubereitungen zur behandlung der urolithiasis
US5244913A (en) * 1991-11-19 1993-09-14 Baxter International Inc. Compositions and methods for dissolving body calculi
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) * 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) * 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
AU735056B2 (en) * 1996-10-23 2001-06-28 Dow Chemical Company, The Water-soluble polymers for the reduction of dietary phosphate or oxalate absorption
US5985938A (en) * 1997-11-05 1999-11-16 Geltex Pharmaceuticals, Inc. Method for reducing oxalate

Similar Documents

Publication Publication Date Title
JP2001521902A5 (cg-RX-API-DMAC7.html)
WO1999033452A3 (en) Amine-containing copolymers as bile acid sequestrants
JP2004535384A5 (cg-RX-API-DMAC7.html)
JP2004528332A5 (cg-RX-API-DMAC7.html)
JP2005533531A5 (cg-RX-API-DMAC7.html)
JP2004526778A5 (cg-RX-API-DMAC7.html)
JP2007506838A5 (cg-RX-API-DMAC7.html)
JPH11152398A5 (cg-RX-API-DMAC7.html)
CA2444046A1 (en) Use of colesevelam in reducing serum glucose
EP1645278A3 (en) Use of aliphatic polyamines for reducing oxalate
EP0970819A3 (en) Ink-jet recording element containing polymeric mordant
EP0827027A3 (en) Curable compositions
JP2004520473A5 (cg-RX-API-DMAC7.html)
JP2003500522A5 (cg-RX-API-DMAC7.html)
KR950031088A (ko) 교차 결합된 음이온 교환 입자 및 그 제조 방법
EP0391413A3 (en) Filled polymeric blend
ATE273341T1 (de) Strikt alternierende poly(alkylenoxid)copolymere
EP0838487A3 (en) Polyether copolymer and polymer solid electrolyte
CA2481365A1 (en) Occlusive composition comprising a poly (2-cyanoacrylate) monomer
JP2003518152A5 (cg-RX-API-DMAC7.html)
EP1138730A3 (en) Aqueous polymer emulsions
JP2002544214A5 (cg-RX-API-DMAC7.html)
JP2001525340A5 (cg-RX-API-DMAC7.html)
JP2006503143A5 (cg-RX-API-DMAC7.html)
JP2004506769A5 (cg-RX-API-DMAC7.html)